No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Autografts
-
Bendamustine Hydrochloride
-
Boronic Acids / administration & dosage
-
Bortezomib
-
Combined Modality Therapy
-
Consolidation Chemotherapy
-
Cyclophosphamide / administration & dosage
-
Dexamethasone / administration & dosage
-
Drug Discovery
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Induction Chemotherapy
-
Lenalidomide
-
Maintenance Chemotherapy
-
Melphalan / administration & dosage
-
Multiple Myeloma / therapy*
-
Neoplasm, Residual
-
Nitrogen Mustard Compounds / administration & dosage
-
Pyrazines / administration & dosage
-
Remission Induction
-
Thalidomide / administration & dosage
-
Thalidomide / analogs & derivatives
-
Transplantation Conditioning
Substances
-
Boronic Acids
-
Nitrogen Mustard Compounds
-
Pyrazines
-
Thalidomide
-
Bortezomib
-
Dexamethasone
-
Cyclophosphamide
-
Bendamustine Hydrochloride
-
Lenalidomide
-
Melphalan